» Articles » PMID: 30047825

In Vitro Culture of Murine Megakaryocytes from Fetal Liver-derived Hematopoietic Stem Cells

Overview
Journal Platelets
Publisher Informa Healthcare
Specialty Hematology
Date 2018 Jul 27
PMID 30047825
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Megakaryocytes (MKs) are specialized precursor cells committed to producing and proliferating platelets. In a cytoskeletal-driven process, mature MKs generate platelets by releasing thin cytoplasmic extensions, named proplatelets, into the sinusoids. Due to knowledge gaps in this process and mounting clinical demand for non-donor-based platelet sources, investigators are successfully developing artificial culture systems to recreate the environment of platelet biogenesis. Nevertheless, drawbacks in current methods entail elaborate procedures for stem cell enrichment, extensive growth periods, low MK yield, and poor proplatelet production. We propose a simple, robust method of primary MK culture that utilizes fetal livers from pregnant mice. Our technique reduces expansion time to 4 days, and generates ~15,000-20,000 MKs per liver. Approximately, 20-50% of these MKs produce structurally dense, high-quality proplatelets. In this review, we outline our method of MK culture and isolation.

Citing Articles

Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36.

Barrachina M, Pernes G, Becker I, Allaeys I, Hirsch T, Groeneveld D Nat Cardiovasc Res. 2024; 2(8):746-763.

PMID: 39195958 PMC: 11909960. DOI: 10.1038/s44161-023-00305-y.


Cell cycle-dependent centrosome clustering precedes proplatelet formation.

Becker I, Wilkie A, Nikols E, Carminita E, Roweth H, Tilburg J Sci Adv. 2024; 10(25):eadl6153.

PMID: 38896608 PMC: 11186502. DOI: 10.1126/sciadv.adl6153.


The role of PALLD-STAT3 interaction in megakaryocyte differentiation and thrombocytopenia treatment.

Li G, Jiang H, Wang L, Liang T, Ding C, Yang M Haematologica. 2024; 109(11):3693-3704.

PMID: 38813732 PMC: 11532707. DOI: 10.3324/haematol.2024.285242.


Evidence for a cytoplasmic proplatelet promoting factor that triggers platelet production.

Italiano Jr J, Machlus K Haematologica. 2024; 109(7):2341-2345.

PMID: 38426280 PMC: 11215393. DOI: 10.3324/haematol.2023.284755.


ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity.

Ranjit S, Wang Y, Zhu J, Cheepala S, Schuetz E, Cho W Drug Resist Updat. 2023; 72:101017.

PMID: 37988981 PMC: 10874622. DOI: 10.1016/j.drup.2023.101017.


References
1.
Italiano Jr J, Lecine P, Shivdasani R, Hartwig J . Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol. 1999; 147(6):1299-312. PMC: 2168104. DOI: 10.1083/jcb.147.6.1299. View

2.
van den Oudenrijn S, von dem Borne A, de Haas M . Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000; 28(9):1054-61. DOI: 10.1016/s0301-472x(00)00517-8. View

3.
Mattia G, Vulcano F, Milazzo L, Barca A, Macioce G, Giampaolo A . Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002; 99(3):888-97. DOI: 10.1182/blood.v99.3.888. View

4.
Eto K, Murphy R, Kerrigan S, Bertoni A, Stuhlmann H, Nakano T . Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A. 2002; 99(20):12819-24. PMC: 130543. DOI: 10.1073/pnas.202380099. View

5.
Schipper L, Brand A, Reniers N, Melief C, Willemze R, Fibbe W . Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol. 2003; 31(4):324-30. DOI: 10.1016/s0301-472x(03)00004-3. View